United Kingdom (UK) Theranostics Market (2025-2031) | Value, Competitive Landscape, Analysis, Share, Forecast, Trends, Segmentation, Companies, Industry, Size & Revenue, Growth, Outlook

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United Kingdom (UK) Country Macro Economic Indicators

3.2 United Kingdom (UK) Theranostics Market Revenues & Volume, 2021 & 2031F

3.3 United Kingdom (UK) Theranostics Market - Industry Life Cycle

3.4 United Kingdom (UK) Theranostics Market - Porter's Five Forces

3.5 United Kingdom (UK) Theranostics Market Revenues & Volume Share, By Product Type, 2021 & 2031F

3.6 United Kingdom (UK) Theranostics Market Revenues & Volume Share, By Application, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of chronic diseases in the UK, leading to higher demand for personalized medicine solutions like theranostics

4.2.2 Growing adoption of advanced diagnostic technologies in healthcare facilities across the UK

4.2.3 Government initiatives and funding to promote research and development in the field of theranostics

4.3 Market Restraints

4.3.1 Stringent regulatory requirements and approval processes for theranostic products in the UK

4.3.2 High costs associated with implementing theranostic technologies and treatments

4.3.3 Limited awareness among healthcare professionals and patients about the benefits of theranostics

6.1 United Kingdom (UK) Theranostics Market, By Product Type

6.1.1 Overview and Analysis

6.1.2 United Kingdom (UK) Theranostics Market Revenues & Volume, By Product Type, 2021- 2031F

6.1.3 United Kingdom (UK) Theranostics Market Revenues & Volume, By Polymerase Chain Reaction (PCR), 2021- 2031F

6.1.4 United Kingdom (UK) Theranostics Market Revenues & Volume, By Immunohistochemistry (IHC), 2021- 2031F

6.1.5 United Kingdom (UK) Theranostics Market Revenues & Volume, By In Situ Hybridization (ISH), 2021- 2031F

6.1.6 United Kingdom (UK) Theranostics Market Revenues & Volume, By Sequencing, 2021- 2031F

6.1.7 United Kingdom (UK) Theranostics Market Revenues & Volume, By Others, 2021- 2031F

6.2 United Kingdom (UK) Theranostics Market, By Application

6.2.1 Overview and Analysis

6.2.2 United Kingdom (UK) Theranostics Market Revenues & Volume, By Oncology, 2021- 2031F

6.2.3 United Kingdom (UK) Theranostics Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F

6.2.4 United Kingdom (UK) Theranostics Market Revenues & Volume, By Neurological Disorders, 2021- 2031F

6.2.5 United Kingdom (UK) Theranostics Market Revenues & Volume, By Immunological Disorders, 2021- 2031F

6.2.6 United Kingdom (UK) Theranostics Market Revenues & Volume, By Others, 2021- 2031F

7.1 United Kingdom (UK) Theranostics Market Export to Major Countries

7.2 United Kingdom (UK) Theranostics Market Imports from Major Countries

8.1 Adoption rate of theranostic technologies in UK healthcare institutions

8.2 Number of research grants and funding allocated for theranostics projects in the UK

8.3 Patient outcomes and treatment efficacy improvements attributed to theranostics in the UK

9.1 United Kingdom (UK) Theranostics Market Opportunity Assessment, By Product Type, 2021 & 2031F

9.2 United Kingdom (UK) Theranostics Market Opportunity Assessment, By Application, 2021 & 2031F

10.1 United Kingdom (UK) Theranostics Market Revenue Share, By Companies, 2024

10.2 United Kingdom (UK) Theranostics Market Competitive Benchmarking, By Operating and Technical Parameters